GLP-1 receptor agonists, like Semaglutide, are transforming diabetes and obesity management—but their effects on gastric emptying are disrupting perioperative care. In this episode of the NYSORA Podcast, Dr. Hadzic dives into the conflicting guidelines, the latest evidence, and how tools like point-of-care ultrasound (POCUS) can save the day. Learn how to minimize aspiration risks, avoid case cancellations, and keep your OR running smoothly with practical, patient-focused strategies.

Where else to find us:
Web- ⁠⁠http://www.nysora.com⁠⁠

Instagram- ⁠⁠instagram.com/nysora.inc/ ⁠⁠

LinkedIN- ⁠⁠linkedin.com/company/nysora-inc/⁠⁠

Facebook- ⁠⁠facebook.com/nysora⁠⁠

Twitter- ⁠⁠x.com/nysora⁠⁠

TikTok- ⁠⁠tiktok.com/@nysora_inc⁠⁠

--------------------------------------------------------- ⁠⁠

#nysora⁠⁠ ⁠⁠#regionalanesthesia⁠⁠ ⁠⁠#anesthesia⁠⁠

Disclaimer: Medicine is an ever-changing science. As new research and clinical experience broaden, changes in treatment and drug therapy are required. The authors and publishers have checked with sources believed to be reliable in efforts to provide accurate information within the available or accepted standards of care. However, given the possibility of human error or changes in medical practice, neither the authors nor the publisher, nor any other party involved in the preparation of this platform warrants that the information contained herein is in every aspect accurate or complete, and they disclaim all responsibility for any errors or omissions for the results obtained from the use of the information contained in this work. Readers are advised to confirm the information contained herein with other sources. For example, readers are advised to check the product information of each drug mentioned, and that any information contained on NYSORA's Podcast is accurate.

GLP-1 Agonists and Anesthesia: Navigating the Risk, Avoiding the Chaos

Anesthesia Updates

GLP-1 Agonists and Anesthesia: Navigating the Risk, Avoiding the Chaos